Picking your Holiday wines this season this year may be challenging as we are still facing pandemic times and gatherings will be limited to small crowds. We imagine most people’s Holiday celebrations to be long meals that may begin with snacks and noshes, extend through appetizers and main courses and end, perhaps hours later, with desserts. The liveliness that comes with good acidity is in effect a survival strategy. Such wines will rejuvenate, even as all that food pushes you toward a comatose state. The French naturally have a term for this characteristic in wines, ‘digestibilité’, wines that are delicious and easy to drink without being freighted with excess or weighing too heavily in the gut...
Optional Cost: $70 plus tax for four bottles of wine plus a seminar with a certified sommelier and educator. It is not required to purchase the wines or buy all 4 bottles. See below for cheese pairings.
We have again arranged a wine tasting in partnership with Public Wines, 23 Witherspoon St. Our certified Sommelier and educator for the evening will be Sebastian Koncurat, who has 20 years of experience in the wine and culinary industries.
Click here for the description of the four holiday wines, and how to purchase them. Further details plus cheese pairings will be sent to registrants.
Please purchase or reserve wines by noon on Tuesday, November 30th. This will help Public Wine order enough in advance.
Please note that if you buy 12 bottles or more, you can get a 15% discount by using promotional code PA3.
Public offers free delivery to the following zip codes: 08502, 08504, 08525, 08528, 08534, 08536,08540,08542,08553, and 08558. Promotional code: Freeship
If you live outside these zip codes, please order online or call and pick up at the store. If you have questions for Public Wine, please call 609 924 0750 and they will be happy to help you. Please mention PA3 wine tasting.
Alexandre-Bonnet-Grande-Reserve-Brut-Champagne: Fromager D’Affionis
La-Patience-Rose-2020: Le Chevrot Goat
Please join us for what will no doubt be a fascinating look into the use of the gene editing technology CRISPR to detect - and potentially destroy- viruses. This will be a nice complement to Shirley Tilghman's talk on the ethical considerations and regulation of CRISPR in 2018.
Cameron Myhrvold is an Assistant Professor of Molecular Biology at Princeton University. His work specializes in the development of CRISPR-based technologies for studying RNA, with an emphasis on detecting and destroying RNA viruses. He received a PhD in Systems Biology from Harvard in 2016. His PhD studies in synthetic biology and nucleic acid nanotechnology, supported by a Fannie and John Hertz Foundation fellowship, involved the development of three technologies that demonstrated a variety of applications for self-assembled nanostructures. During his postdoc, he turned his attention towards the RNA-targeting CRISPR effector protein Cas13, where he has led or co-led the development of four Cas13-based technologies, including CARMEN, CARVER, and SHINE.
Please join us for a discussion with Professor Keith Whittington on this important and timely topic. His remarks will be followed by the opportunity for Q&A.
Keith E. Whittington is the William Nelson Cromwell Professor of Politics at Princeton University and is currently the chair of Academic Freedom Alliance. He works on American constitutional history, politics and law, and on American political thought. He is the author of Repugnant Laws: Judicial Review of Acts of Congress from the Founding to the Present and Speak Freely: Why Universities Must Defend Free Speech, among other works. He has been a visiting professor at Harvard Law School, Georgetown University Law Center, and the University of Texas School of Law, and he is a member of the American Academy of Arts and Sciences and serves on the Presidential Commission on the Supreme Court of the United States. He did his undergraduate work at the University of Texas at Austin and completed his Ph.D. in political science at Yale University.
His book Speak Freely was the Princeton Pre-read selection for 2018.
Professor Whittington on Challenges to Academic Freedom and Campus Free Speech (
Wednesday, December 8, 2021 - 7:30 PM to
Note: This event has been recorded and may be viewed here
PA3 INVITES YOU TO “SECOND TUESDAYS”
A PRINCETON PROPELLER ZOOM EVENT
UWMA @ QUADRANGLE CLUB
NAVIGATORS & THE CURIOUS
Please Join Us with Cocktails & Hors d’oeuvres
WHEREVER YOU ARE
7 P, EASTERN TIME (USA) -- TUESDAY, November 9th, 2021
“Combining Cell Fate Reprogramming & Immunotherapy: A Revolutionary Approach for Cancer Treatment”
Speaker: Filipe Pereira, PhD
Founder & Head of Innovation, Asgard Therapeutics
Associate Professor, Lund University
Cancer is the second-leading cause of human death, with more than 10 million lives lost annually and a cost
burden topping 1 trillion USD worldwide. For the 80 percent of tumors that are solid and hard-to-treat, current
standards of care (surgery, radiotherapy, chemotherapy) are often inadequate. Even the newer approaches of
modern immunotherapy (immune checkpoint inhibitors, CAR T-cell therapies, cancer vaccines) often fall short
in more than half of patients, due to lack of antigen presentation, tumor heterogeneity, and immune evasion.
ENTER: a new gene therapy for cancer based on cellular reprogramming, co-developed by our speaker. This
technology reprograms cancer cells into dendritic cells that present their own tumor antigens for destruction.
Following background on ways to reprogram cells, our speaker will: detail his current work; provide previously
unpublished data; touch on challenges that remain before first-in-human trials can take place; and mull
prospects for cell fate reprogramming to transform the current cancer immunotherapy landscape.
THIS PAGE WAS CREATED BY AND FOR THE PRINCETON AREA ALUMNI ASSOCIATION. INFORMATION ON THIS PAGE IS INTENDED FOR INDIVIDUAL COMMUNICATION OF A
PERSONAL NATURE AMONG PRINCETONIANS. USE OF THIS INFORMATION FOR ANY OTHER PURPOSE IS STRICTLY PROHIBITED. THE PAAA IS SOLELY RESPONSIBLE FOR
THE CONTENT ON THIS PAGE. ALTHOUGH WE MAKE EVERY EFFORT TO KEEP THIS INFORMATION ACCURATE, WE CANNOT GUARANTEE IT.